BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30295095)

  • 1. Pathogenesis of adult onset still's disease: current understanding and new insights.
    Ruscitti P; Giacomelli R
    Expert Rev Clin Immunol; 2018 Nov; 14(11):965-976. PubMed ID: 30295095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.
    Li S; Zheng S; Tang S; Pan Y; Zhang S; Fang H; Qiao J
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):71-81. PubMed ID: 31147820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging biological therapy in adult-onset Still's disease.
    Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adult-onset still's disease: up to date.
    Yoo DH
    Expert Rev Clin Immunol; 2017 Sep; 13(9):849-866. PubMed ID: 28540751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.
    Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P
    Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies.
    Ruscitti P; Ursini F; Cipriani P; De Sarro G; Giacomelli R
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1089-1097. PubMed ID: 28870100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.
    Chen PK; Chen DY
    J Immunol Res; 2021; 2021():8998358. PubMed ID: 34239943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current concepts on the physiopathology of adult-onset Still's disease].
    Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
    Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
    Ruscitti P; Cipriani P; Ciccia F; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Guggino G; Di Bartolomeo S; Triolo G; Giacomelli R
    Clin Exp Immunol; 2016 Oct; 186(1):30-8. PubMed ID: 27317930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
    Sfriso P; Bindoli S; Galozzi P
    Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms, biomarkers and targets for adult-onset Still's disease.
    Feist E; Mitrovic S; Fautrel B
    Nat Rev Rheumatol; 2018 Oct; 14(10):603-618. PubMed ID: 30218025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset Still's disease as a cutaneous marker of systemic disease.
    Damevska K; França K; Nikolovska S; Gucev F
    Clin Dermatol; 2019; 37(6):668-674. PubMed ID: 31864446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics for the treatment of adult-onset still's disease.
    Yoo DH
    Expert Opin Biol Ther; 2019 Nov; 19(11):1173-1190. PubMed ID: 31379214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Still's disease in children and adults].
    Hedrich CM; Günther C; Aringer M
    Hautarzt; 2017 Jun; 68(6):497-511. PubMed ID: 28451698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
    Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
    Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How I treat patients with adult onset Still's disease in clinical practice.
    Govoni M; Bortoluzzi A; Rossi D; Modena V
    Autoimmun Rev; 2017 Oct; 16(10):1016-1023. PubMed ID: 28778712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.